Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TCRαβ+ Cell Deleted Versus Traditional Haploidentical Hematopoietic Stem Cell Transplantation ：A Single-center, Prospective, Non-randomized Controlled Clinical Study

NCT06423131 is registered in ClinicalTrials.gov with Sijia Gu as lead sponsor.

NCT NCT06423131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06423131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TCRαβ+ Cell Deleted Versus Traditional Haploidentical Hematopoietic Stem Cell Transplantation ：A Single-center, Prospective, Non-randomized Controlled Clinical Study
Lead sponsor
Sijia Gu
Phase
Not applicable
Overall status
Recruiting
Start date
May 26, 2024
Completion date
March 31, 2028
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

child, only, graft-versus-host disease, haploidentical hematopoietic stem cell transplantation, hematopoietic stem cell transplantation